www.regonline.co.uk/innate2014
Wednesday, 12 November 2014 17:00
Peninsula Square
London
SE10 0DX
United Kingdom
This year there are three main topics for discussion
- The Innate Immunity Interactions with Pathogens
- Interactions of the Innate and Adaptive Immune Systems
- Therapeutic applications of the Innate Immune system
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding an organisms first line of defense
The deadline for abstract submissions for oral presentation is July 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at: www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
Infectious disease are still a major cause of morbidity and mortality worldwide. Innate immunity is of paramount importance for the control of pathogens in the early stages of the infection and for the engenderment and expansion of acquired immunity. This will be a premier forum for the presentation of cutting-edge research on how the interaction between innate immune mechanisms and pathogens impacts on host resistance, immunoevasion, immunodeficiencies and vaccine efficacy, providing
a deep insight into future research and more rational measures to prevent and treat infectious diseases of humans and animals.
Day 2: Investigating interactions of the Innate and Adaptive Immune Systems
The cells of the innate immune system play a crucial part in the initiation and subsequent direction of adaptive immune responses. The session will discuss this role of the innate immune system, drawing on new research and the opportunity for networking and informal discussion.
Day 3: Therapeutic applications of the Innate Immune system
The identification of antigen recognition receptors for innate immunity has sparked great interest in therapeutic manipulation of the innate immune system. For example Toll-like receptor agonists are being developed for the treatment of cancer, allergies and viral infections, and as adjuvants for cancer and disease vaccines. This session will explore current research and applications of the innate system for therapeutic applications. There will be plenty of opportunity for discussion and debate and we encourage submission of abstracts for both oral and poster presentation.
Sepsis as a Model of Impaired Communication between the Innate and Adaptive Immune Systems
Dr Jim Faix, Director of Chemistry & Immunology, Director of Point-of-Care Testing, Department of Pathology, Stanford University Medical Center, Stanford, USAExploring pathogen recognition in innate immunity using Drosophila as a model host
Dr Petros Ligoxygakis, Lecturer of Genetics, University of Oxford, UK
The MHC class II-associated invariant chain controls innate and adaptive immunity in B cells
Dr Bénédicte Manoury, Présentation des antigènes: mécanismes et modulation par les récepteurs Toll-like, Hôpital Necker, Paris, France
B-cells at the interface between innate and acquired immunity to bacterial pathogens
Dr Pietro Mastroeni, Reader in Infection and Immunity, University of Cambridge, UK
Regulation of autoimmune myocarditis and inflammatory cardiomyopathy by innate immunity
Dr Przemyslaw Blyszczuk, Junior Group Leader, Cardioimmunology, University of Zurich, Switzerland
Novel insights into the regulation of Toll-like receptor signalling
Dr Sinead Miggin, Lecturer and Principal Investigator, National University of Ireland Maynooth, Ireland
High-intensity ultra-short electric pulse applications in modulating innate immunity
Dr Sunil K. Joshi, Assistant Professor of Cellular Immunology School of Medical Diagnostic and Translational Sciences, Frank Reidy Research Center for Bioelectrics, Old Dominion University,Virginia, USA
Interaction of HIV with plasmacytoid dendritic cells and its relevance for HIV pathogenesis
Dr Adriano Boasso, Principal Investigator – Research Fellow, Imperial College London, UK
Novel Interactions between Fas and TLR signalling
Dr Elizabeth Brint, Lecturer and Principal Investigator,University College Cork, Ireland
M1/M2 Macrophages: A Copernican Revelation in Immunology
Dr Charles Mills, BioMedical Consultants, United States
Additional confirmed Speakers
- Dr Claudia Monaco, Imperial College London, United Kingdom
- Dr Sema Becerik, Ege University, Turkey
- Dr Sophia Karagiannis, St. John’s Institute of Dermatology, King’s College London School of Medicine, UK
- Dr Hans U. Lutz, Institute of Biochemistry, Swiss Federal Institute of Technology, Switzerland